Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Ononin suppresses thyroid cancer cell proliferation and induces apoptosis by inhibiting NSUN6-mediated m5C methylation of SKP2.

Created on 12 Nov 2026

Authors

Liangliang Du, Yuwei Dai, Jiayu Sui, Yuwen Liao, Yonghe Liu, Liusi Du, Douyun Zeng

Published in

Endocrine research. Pages 1-14. Nov 11, 2026. Epub Nov 11, 2026.

Abstract

This study investigated the anti-tumor efficacy of ononin in thyroid cancer (TC) and its molecular mechanisms.
In vitro, TPC-1 and IHH-4 cells treated with ononin were assessed for proliferation, apoptosis, global m5C levels, and the NSUN6-SKP2 interaction. A xenograft mouse model was used for in vivo validation.
Ononin suppressed TC cell proliferation, induced apoptosis, and reduced NSUN6-mediated m5C modification. Mechanistically, NSUN6 directly bound SKP2 mRNA and deposited m5C at site 2576, enhancing its stability. Overexpression of NSUN6 or SKP2 reversed ononin's anti-tumor effects. In vivo, ononin inhibited tumor growth without significant toxicity to normal thyroid epithelial cells or major mouse organs.
Ononin exerts anti-TC activity via the NSUN6/SKP2 axis, identifying NSUN6 as a potential therapeutic target and ononin as a candidate compound for TC worthy of further clinical investigation.

PMID:
43015002
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement